2020-06-22
CTBE conducted FDA Pre-Submission with the U.S, Food and Drug Administration (FDA) successfully. For Reference
CTBE conducted FDA Pre-Submission with the U.S, Food and Drug Administration (FDA) successfully. For Reference
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
2023-11-15
Kiyotaka Iwasaki will be on stage as a speaker at the 1st Japanese Knee Society Conference, held on December 8th, 2023
2023-10-12
CTBE will attend JHVS 2023 in Yokohama
2023-07-18
We obtained a license for manufacturing and marketing of first-class medical devices.